# OnCo record postmonarch (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/postmonarch/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "postmonarch", "NCT05169567" ;
  schema:name "postMONARCH"@en ;
  schema:description "Continuing CDK4/6 blockade with a different drug after the first one fails gives a small but real benefit."@en ;
  schema:url <https://onco.cc/trials/postmonarch/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05169567> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2022-03-11" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/hr-positive-metastatic-post-cdk46/> ;
  onco:technologies <https://onco.cc/technologies/cdk46-inhibitor/> ;
  onco:targets <https://onco.cc/targets/cdk4-6/> ;
  onco:drugs <https://onco.cc/drugs/abemaciclib/> ;
  onco:companies <https://onco.cc/companies/eli-lilly/> .
